Drugs / Nebicapone
Trials 11 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 19 trials | ||||||
| Phase 1 | NCT02779348 | Sep → Dec 2006 | — | Bial - Portela C S.A. | Completed | No outcome recorded |
| Phase 1 | NCT02772614 | Jan → Feb 2006 | Parkinson disease | Bial - Portela C S.A. | Completed | No outcome recorded |
| Phase 1 | NCT02778594 | Sep → Nov 2005 | Parkinson disease | Bial - Portela C S.A. | Completed | No outcome recorded |
| Phase 1 | NCT02774564 | Sep → Nov 2005 | Parkinson disease | Bial - Portela C S.A. | Completed | No outcome recorded |
| Phase 1 | NCT02772627 | Sep → Dec 2001 | Parkinson disease | Bial - Portela C S.A. | Completed | No outcome recorded |
| Phase 1 | NCT02763839 | Apr → Jul 2001 | Parkinson disease | Bial - Portela C S.A. | Completed | No outcome recorded |
| Phase 1 | NCT02763852 | Apr → Jul 2001 | Parkinson disease | Bial - Portela C S.A. | Completed | No outcome recorded |
| Phase 1 | NCT02763800 | Sep 2000 → Jan 2001 | Parkinson disease | Bial - Portela C S.A. | Completed | No outcome recorded |
| Phase 1 | NCT02763787 | Apr → Jun 2000 | Parkinson disease | Bial - Portela C S.A. | Completed | No outcome recorded |
| Phase 22 trials | ||||||
| Phase 2 | NCT03103399 | Sep 2006 → Sep 2007 | Parkinson disease | Bial - Portela C S.A. | Completed | No outcome recorded |
| Phase 2 | NCT02834507 | Mar → Nov 2005 | Parkinson disease | Bial - Portela C S.A. | Completed | No outcome recorded |
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03097211 Background | Jul → Oct 2006 | Parkinson disease | Bial - Portela C S.A. | Completed | No outcome recorded |
Evidence & citations 7 cited values
Every value below carries the sentence it was read from. 13 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Nebicapone | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02772627 ↗ |
| Known as | BIA 3-202 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02778594 ↗ |
| Known as | Nebicapona | ChEMBL registry synonym — accepted as the source's own label CHEMBL160038 ↗ |
| Action | Inhibit | “Catechol O-methyltransferase inhibitor” CHEMBL160038 ↗ |
| Modality | Small molecule | — CHEMBL160038 ↗ |
| Route | Oral | “BIA 3-202 was administered in the form of oral tablets” NCT02763787 ↗ |
| Target | COMT | “Catechol O-methyltransferase inhibitor” CHEMBL160038 ↗ |